Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

Clinical trial NCT02807844 · COMPLETED

Trial details

NCT number: NCT02807844
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Pancreatic Carcinoma Melanoma Endometrial Carcinoma

Start date: 2016-06-29
Primary completion: 2020-06-04
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.